Office of Research & Development |
|
Project Number: | I01BX004841-01A1 |
| Title: | Preclinical investigation of PI3K inhibition and immune checkpoint blockade combination therapy for treatment of Merkel cell carcinoma using humanized mouse models |
| Principal Investigator: | Ling Gao |
| Location: | Long Beach, CA |
| Congressional District Code: | 47 |
| Research Service: | Biomedical Laboratory R&D |
| Project Period: | April 2020 - March 2024 |
| FY 2023 Funding Amount: | $164,950 |
| Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |